Latest Headlines

31. ALZpath Broadens Strategic Agreement With Alamar Biosciences To Advance Clinical Diagnostics For Alzheimer's Disease 7/23/2026

    ALZpath, Inc., a leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced the expansion of their strategic agreement with Alamar Biosciences into clinical diagnostics.

32. Revvity Announces Development Of High-Throughput T-SPOT.TB Automated Platform For Clinical Labs 7/23/2026

    Revvity, Inc. today announced the development of the T-SPOT A201, a next-generation high-throughput automated platform designed to support the performance advantages of T-SPOT.TB testing for large-volume clinical labs, enabling a reliable, accurate solution for latent tuberculosis (TB) detection.

33. Alcohol-Free Solution For Cell Freezing 7/23/2026

    CoolCell cell freezing containers from Azenta Life Sciences deliver reproducible cryopreservation while eliminating the need for alcohol-based freezing methods.

34. bioAffinity Technologies And Pictor, Inc. Partner To Develop And Commercialize Bioaffinity's Diagnostics For Asthma And COPD 7/22/2026
35. Cancer Cell Diagnostics (CCDx) Debuts Whole-Cell Genomic Profiling To Redefine Liquid Biopsy 7/22/2026

    Cancer Cell Diagnostics today announced the commercial launch of its CellSight DNA comprehensive genomic profiling test. This test is built on a fundamentally distinct source material from conventional liquid biopsy.

36. Cizzle Bio Launches CIZ1B Biomarker Blood Test For Early Lung Cancer 7/22/2026

    Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early lung and gastric cancers, today announced the commercial launch of its proprietary CIZ1B Biomarker Blood Test for Lung Cancer for licensed health care providers in Dallas-Fort Worth and San Antonio.

37. Cepheid To Unveil Third-Generation GeneXpert® System At ADLM 2026, Advancing Molecular Diagnostic Capabilities 7/22/2026

    Cepheid, a Danaher company, and a leader in molecular diagnostics, will unveil the third generation of the GeneXpert system at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting in a special booth presentation on Tuesday, July 28.

38. Roche Showcases Intelligent Lab Solutions And High-Precision Instruments At ADLM 2026 To Help Laboratories Address Workforce And Workflow Challenges 7/22/2026
39. Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies In India For Tuberculosis Test On PCR Platform 7/22/2026

    Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the Company's joint venture in India, is initiating clinical studies for the tuberculosis test on the CoSara PCR Pro® instrument.

40. Steps Taken To Enhance National Preparedness Against Emerging Infectious Diseases 7/21/2026

    The Union Health Ministry regularly reviews and strengthens its preparedness for the detection and response to emerging infectious diseases through various national programs and institutions including the Viral Research and Diagnostic Laboratories (VRDL) network, genomic surveillance initiatives and wastewater surveillance for early detection of pathogens of public health importance. The preparedness is further strengthened through participation in simulation exercises, mock drills and rapid outbreak response mechanisms.